FORDOZPHARMA
Live / Registered — Registered — Section 8 accepted (as of 15 May 2025)
What this means for you
Registered since 22 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87959296
- Registration number
- 5661159
- Mark type
- Word mark
- Filed
- 12 Jun 2018
- Published for opposition
- 06 Nov 2018
- Registered
- 22 Jan 2019
- Attorney of record
- Kenneth F. Florek
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Owner
- ForDoz Pharma Corp, East Windsor, NJ, US
- ForDoz Pharma Corp, East Windsor, NJ, US
- ForDoz Pharma Corp, East Windsor, NJ, US
Prosecution history
- 15 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 15 May 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 15 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 14 May 2025 — POST REGISTRATION ACTION MAILED - SEC. 8
- 14 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 12 Mar 2025 — POST REGISTRATION ACTION MAILED - SEC. 8
- 12 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jul 2024 — TEAS SECTION 8 RECEIVED
- 22 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Nov 2018 — PUBLISHED FOR OPPOSITION
- 17 Oct 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Sept 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Sept 2018 — ASSIGNED TO EXAMINER